It's no wonder this company is blasting off like the space shuttle Discovery. It now controls half the world's supply of the Century's most in-demand fuel. Already, demand outstrips supply by 16X. Current estimates have potential gains at as much as 2,840%. You'll see exactly why in this breathtaking report. Just go here.
Another Marvelous Move at Disney
Yesterday The Walt Disney Co (NYSE: DIS) took a nosedive of almost 3% on the news that they were going to purchase Marvel for $4 billion. Analysts believed that Disney had overpaid for the company – one just downgraded by JPM.
After all, when they picked up Pixar they paid only a 4% premium, while for Marvel they ponied up a 29% premium. Did Disney overpay for Marvel?
Absolutely not.
As Disney opened slightly positive this morning, the street may be coming to their senses. Rest assured, in a short period of time it will become apparent that Disney made another masterful move of picking up this classic character franchise.
While new character creations hit the markets and TV screens every year, some are timeless and iconic – Marvel has these. Imagine the income on just one more mega-hit Ironman movie, or another classic character from Marvel’s vaults.
Disney has been suffering from it’s inability to create new characters that have the same appeal as their older ones. Instead of beating a dead horse, they’ve been smart enough to pick up as many new characters – already beloved – as they can.
With Disney’s distribution and brand protection, they can leverage characters better than anyone. This move shows that Disney sans Eisner can be successful and, we suspect, very profitable.
Companies mentioned in this article: DIS.
- Disney’s Spidey Sense is Tingling
- Defining Investment Jargon: Stalking-Horse Bid
- Another Monday… Another “Game-Changing” Deal
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed